Branca, Jacopo Junio Valerio

Di Cesare Mannelli, Lorenzo

Gulisano, Massimo

Morucci, Gabriele

Pacini, Alessandra

Pacini, Stefania

Paternostro, Ferdinando

Ruggiero, Marco

English

Branca, JACOPO JUNIO VALERIO

DI CESARE MANNELLI, Lorenzo

Florence Research

IJAE Vo l .  119,  n .  1  (Supp lem ent) :  135,  2014© 2014 Firenze University Press ht tp://www.fupress .com/ijaeITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGYGc-protein derived macrophage activating factor (GcMAF) counteracts the neuronal damage induced by oxaliplatin Gabriele Morucci1, Jacopo J. V. Branca1, Massimo Gulisano1, Marco Ruggiero2, Ferdinando Paternostro1, Alessandra Pacini1, Lorenzo Di Cesare Mannelli3, Stefania Pacini11 Department of Experimental and Clinical Medicine, University of Firenze, 50134 Firenze, Italy2 Department of Clinical and Biomedical Experimental Sciences, University of Firenze, 50134 Firenze, Italy3 Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Firenze, 50134 Firenze, ItalyOxaliplatin-based regimens are effective in metastasised advanced cancers. How-ever, a major limitation to their use is represented by neurotoxicity leading to periph-eral neurophaty (Wolf et al., 2008). In this study we evaluate the effects of an immu-notherapeutic agent (Gc protein-derived macrophage activating factor, GcMAF) in preventing oxaliplatin-induced neuronal damage and in restoring microglial activa-tion. The effects of oxaliplatin was studied in human neurons (SH-SY5Y) and micro-glial cells (c13-nj). Cell density, morphology and viability as well as production of cAMP and expression of vascular endothelial growth factor (VEGF), markers of neuron regeneration and markers of microglia activation were determined. GcMAF reverted the damage inflicted by oxaliplatin on human neurons and preserved their viability; it also increased cAMP production, VEGF and neuromodulin expression. GcMAF did not revert the effects of oxaliplatin on microglial cell viability. Howev-er, it induced microglial activation resulting in an increased expression of a specific marker without any increase in cell number. Our results demonstrate that GcMAF may significantly contribute to neutralize the neurotoxicity induced by oxaliplatin, at the same time concurring to an integrated anti-cancer effect.References[1] Wolf et al. (2008) Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment Strat-egies. Eur J Cancer; 44: 1507-1515.KeywordsOxaliplatin, human neurons, human microglia, vitamin D, cancer, immunotherapy, GcMAF.

Gc-protein derived macrophage activating factor (GcMAF) counteracts the neuronal damage induced by oxaliplatin

https://flore.unifi.it/bitstream/2158/918130/1/gc_protein.pdf

Gc-protein derived macrophage activating factor (GcMAF) counteracts the neuronal damage induced by oxaliplatin

Abstract

Similar works

Full text

Available Versions

Florence Research